What’s causing the GT Biopharma, Inc. (GTBP) stock to experience downfall?
GT Biopharma, Inc. (GTBP) has experienced a downfall of 5.91% in the aftermarket. However, the last trading session concluded at $3.72. Demonstration of Novel B7-H3
GT Biopharma, Inc. (GTBP) has experienced a downfall of 5.91% in the aftermarket. However, the last trading session concluded at $3.72. Demonstration of Novel B7-H3
Orbsat Corp. (OSAT) has seen a push of 7.26% in the aftermarket. However, the last trading session closed at $3.72 with a decrease of 4.86%.
Mmtec, Inc. (MTC) has seen an increase of 8.53% in the aftermarket. However, the last trading session closed at $0.783 with a decrease of 4.51%.
Oblong Inc. (OBLG) saw an increase of 5.50% in the aftermarket. However, the last trading session closed at $1.09 with a decrease of 6.03%. Third
Orion Group Holdings, Inc. (ORN) experienced a decrease of 6.88% in the aftermarket. However, the last trading session closed at $3.78 with an increase of
PLAYSTUDIOS, Inc. (MYPS) has seen an increase of 5.26% in the aftermarket. However, the last trading session closed at $4.18 with an increase of 7.73%.
Hycroft Mining Holding Corporation (HYMC) experienced an increase of 6.53% in the aftermarket. However, the last trading session closed at $0.6757 with a decrease of
Copyright©2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.